Drug intelligence / Profile preview

6-grass pollen polymerized extract

Development stage
Phase 3
Lead developer
Inmunotek
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

6-grass pollen polymerized extract is a subcutaneous allergen immunotherapy (AIT) developed by Inmunotek for the treatment of grass pollen-induced allergic rhinitis, allergic rhinoconjunctivitis, and asthma. The extract consists of pollen allergens from six grass species (*Phleum pratense*, *Dactylis glomerata*, *Lolium perenne*, *Poa pratensis*, *Holcus lanatus*, and *Festuca elatior*) that are chemically modified (polymerized) using glutaraldehyde and adsorbed onto aluminum hydroxide. This polymerization process reduces the allergenicity (IgE-binding capacity) of the extracts, thereby improving safety and allowing for accelerated up-dosing schedules while maintaining immunogenicity to induce long-term immune tolerance.

Brand names
AlxoidClustekClustoid
Other names
6-grass mix polymerized extract6-grass pollen polymerized extractsglutaraldehyde-polymerized 6-grass pollen extractglutaraldehyde-polymerized6-grass pollen extractglutaraldehyde-polymerized-6-grass pollen extractglutaraldehyde-polymerized mixture of six grass pollen extractspolymerized 6-grass pollen extractpolymerized6-grass pollen extractpolymerized-6-grass pollen extract
02

Targets

FCER1 (Fc epsilon RI receptor)

Beyond the preview

Go deeper on 6-grass pollen polymerized extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-grass pollen polymerized extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call